NCT06281353View on ClinicalTrials.gov

The Effect of Oral Nanocurcumin as an Adjuvant Therapy for Anogenital Warts: Evaluation of Clinical Improvement, NFĸB, IFN-γ, and FOXP3+TReg From Lesions Tissue

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

August 16, 2022

Primary Completion Date

September 6, 2023

Study Completion Date

September 6, 2023

Conditions
Anogenital Wart
Interventions
DRUG

Curcumin Oral Capsule

Curcumin oral capsule in nano-sized particle.

DRUG

Trichloroacetic acid

TCA 90%

PROCEDURE

Blood sample collection

HIV and CD4+ 4th generation.

PROCEDURE

Cotton swab

Cotton swab for collecting sample from AGW lesions.

Trial Locations (1)

10430

Cipto Mangunkusumo Hospital, Jakarta Pusat

All Listed Sponsors
lead

Indonesia University

OTHER